Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. - Jones,S..; Holmes,F.A.; O'Shaughnessy,J..; Blum,J.L.; Vukelja,S.J.; McIntyre,K.J.; et,al.. (J Clin Oncol, 2009)